Worth reading
40Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
800
Million New Taiwan dollars (joint venture capital)Wording
Avoiding a definitive answer
How definitive the wording is.This transaction
Establishment of a joint venture through joint investmentCounterpartyFormosa Plastics Corporation
Disclosing companyDaicel Corporation
The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
TimelineThe spacing between the points is proportional to the actual number of days.
Target company
Manufacture and sale of chemical products, etc.
Location Kaohsiung City, TaiwanShare capital NT$800 millionDate of incorporation October 2026 (scheduled)
Impact on Business Performance
The impact on consolidated results for the fiscal year ending March 2027 is expected to be minor, but the transaction is expected to contribute to improving the Company's performance and corporate value over the medium to long term.
Procedures and assumptions
Conditions Precedent to ExecutionInternal approvals by the Company and the counterparty, including board resolutions; clearance from competition authorities in Japan and other countries; and approvals and licenses from other relevant authorities as required by law.
Management structure after acquisitionThe corporate name will be 台塑大賽璐精密化學股份有限公司 / Formosa Daicel Advanced Chemicals Co., Ltd. (both planned). The representative will be Chairman Wen-Bee Kuo. Employee terms and treatment: Not disclosed.
| Item | Details |
|---|---|
| Transaction name | Establishment of a joint venture through joint investment |
| Counterparty name | Formosa Plastics Corporation |
| Name of the Subject Company | 台塑大賽璐精密化學股份有限公司 (planned) / Formosa Daicel Advanced Chemicals Co., Ltd. (planned) |
| Business Description of the Subject Company | Manufacture and sale of chemical products, etc. |
| Location of the Subject Company | Kaohsiung City, Taiwan |
| Capital Stock of the Subject Company | NT$800 million |
| Date of Establishment of the Subject Company | October 2026 (scheduled) |
| Voting rights ownership percentage | After 50% (before not disclosed) |
| Impact on Business Performance | The impact on consolidated results for the fiscal year ending March 2027 is expected to be minor, but the transaction is expected to contribute to improving the Company's performance and corporate value over the medium to long term. |
| Date of board resolution | 10 July 2026 |
| Contract Date | August 2026 (planned) |
| Execution Date / Effective Date | Joint venture establishment date: October 2026 (planned); business commencement date: January 2029 (planned) |
| Conditions Precedent to Execution | Internal approvals by the Company and the counterparty, including board resolutions; clearance from competition authorities in Japan and other countries; and approvals and licenses from other relevant authorities as required by law. |
| Management structure after acquisition | The corporate name will be 台塑大賽璐精密化學股份有限公司 / Formosa Daicel Advanced Chemicals Co., Ltd. (both planned). The representative will be Chairman Wen-Bee Kuo. Employee terms and treatment: Not disclosed. |
Items this document does not state (18)
Net Sales of the Subject CompanyOperating Profit of the Subject CompanyNet Income of the Subject CompanyNet Assets of the Subject CompanyAcquisition priceExpenses other than the acquisition priceType of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodNumber of shares acquiredFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Valuation methodologyIndependent valuation institutionSpecial Committee
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In anticipation of expanding global semiconductor demand and increased semiconductor investment in Taiwan, the companies will combine their technological capabilities, sales capabilities, human resources and business networks to establish a new business platform, improve services and quality, expand their business scope and accelerate growth.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.